BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smorodin E, Sergeyev B, Klaamas K, Chuzmarov V, Kurtenkov O. The relation of the level of serum anti-TF, -Tn and -alpha-Gal IgG to survival in gastrointestinal cancer patients. Int J Med Sci 2013;10:1674-82. [PMID: 24151439 DOI: 10.7150/ijms.6841] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Ulsemer P, Toutounian K, Kressel G, Goletz C, Schmidt J, Karsten U, Hahn A, Goletz S. Impact of oral consumption of heat-treated Bacteroides xylanisolvens DSM 23964 on the level of natural TFα-specific antibodies in human adults. Beneficial Microbes 2016;7:485-500. [DOI: 10.3920/bm2015.0143] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
2 Kurtenkov O, Klaamas K. Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer. Dis Markers 2015;2015:761908. [PMID: 26663951 DOI: 10.1155/2015/761908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Kurtenkov O, Klaamas K. Hidden IgG Antibodies to the Tumor-Associated Thomsen-Friedenreich Antigen in Gastric Cancer Patients: Lectin Reactivity, Avidity, and Clinical Relevance. Biomed Res Int 2017;2017:6097647. [PMID: 28316982 DOI: 10.1155/2017/6097647] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
4 Smorodin EP. Prospects and Challenges of the Study of Anti-Glycan Antibodies and Microbiota for the Monitoring of Gastrointestinal Cancer. Int J Mol Sci 2021;22:11608. [PMID: 34769037 DOI: 10.3390/ijms222111608] [Reference Citation Analysis]
5 Peng Y, Zhan XX, Cao Y, Zhang HW, Cao WH, Su YJ, Diao C, Sun QM, Cheng RC. The Potential Action of Thomsen-Friedenreich Monoclonal Antibody (A78-G/A7) in Thyroid Cancer. Onco Targets Ther 2020;13:8677-89. [PMID: 32982276 DOI: 10.2147/OTT.S261685] [Reference Citation Analysis]
6 Zlocowski N, Grupe V, Garay YC, Nores GA, Lardone RD, Irazoqui FJ. Purified human anti-Tn and anti-T antibodies specifically recognize carcinoma tissues. Sci Rep 2019;9:8097. [PMID: 31147593 DOI: 10.1038/s41598-019-44601-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
7 Smorodin E, Sergeyev B, Kurtenkov O, Kuznetsova T, Geller J. IgG Antibodies to GlcNAcβ and Asialo-GM2 (GA2) Glycans as Potential Markers of Liver Damage in Chronic Hepatitis C and the Efficacy of Antiviral Treatment. Dis Markers 2018;2018:4639805. [PMID: 30627223 DOI: 10.1155/2018/4639805] [Reference Citation Analysis]
8 Blsakova A, Kveton F, Kasak P, Tkac J. Antibodies against aberrant glycans as cancer biomarkers. Expert Rev Mol Diagn 2019;19:1057-68. [PMID: 31665948 DOI: 10.1080/14737159.2020.1687295] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kurtenkov O, Innos K, Sergejev B, Klaamas K. The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer. Biomed Res Int 2018;2018:9579828. [PMID: 30105268 DOI: 10.1155/2018/9579828] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Temme JS, Butler DL, Gildersleeve JC. Anti-glycan antibodies: roles in human disease. Biochem J 2021;478:1485-509. [PMID: 33881487 DOI: 10.1042/BCJ20200610] [Reference Citation Analysis]
11 Tikhonov A, Smoldovskaya O, Feyzkhanova G, Kushlinskii N, Rubina A. Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications. Clin Chem Lab Med 2020;58:1611-22. [PMID: 32324152 DOI: 10.1515/cclm-2019-1161] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
12 Guu SY, Lin TH, Chang SC, Wang RJ, Hung LY, Fang PJ, Tang WC, Yu P, Chang CF. Serum N-glycome characterization and anti-carbohydrate antibody profiling in oral squamous cell carcinoma patients. PLoS One 2017;12:e0178927. [PMID: 28594851 DOI: 10.1371/journal.pone.0178927] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]